The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: We aimed to determine the clinicopathological significance of the gross classification of hepatocellular carcinoma (HCC) according to the Korean Liver Cancer Association (KLCA) guidelines. Methods: A retrospective analysis was performed on 242 cases of consecutively resected solitary primary HCC between 2003 and 2012 at Seoul National University Bundang Hospital. The gross classification (vaguely nodular [VN], expanding nodular [EN], multinodular confluent [MC], nodular with perinodular extension [NP], and infiltrative [INF]) was reviewed for all cases, and were correlated with various clinicopathological features and the expression status of “stemness”-related (cytokeratin 19 [CK19], epithelial cell adhesion molecule [EpCAM]), and epithelial-mesenchymal transition (EMT)–related (urokinase plasminogen activator receptor [uPAR] and Ezrin) markers. Results: Significant differences were seen in overall survival (p = .015) and disease-free survival (p = .034) according to the gross classification; INF type showed the worst prognosis while VN and EN types were more favorable. When the gross types were simplified into two groups, type 2 HCCs (MC/NP/INF) were more frequently larger and poorly differentiated, and showed more frequent microvascular and portal venous invasion, intratumoral fibrous stroma and higher pT stages compared to type 1 HCCs (EN/VN) (p < .05, all). CK19, EpCAM, uPAR, and ezrin expression was more frequently seen in type 2 HCCs (p < .05, all). Gross classification was an independent predictor of both overall and disease-free survival by multivariate analysis (overall survival: p = .030; hazard ratio, 4.118; 95% confidence interval, 1.142 to 14.844; disease-free survival: p = .016; hazard ratio, 1.617; 95% confidence interval, 1.092 to 2.394). Conclusions: The gross classification of HCC had significant prognostic value and type 2 HCCs were associated with clinicopathological features of aggressive behavior, increased expression of “stemness”- and EMT-related markers, and decreased survival.
Abstract
Background: We aimed to determine the clinicopathological significance of the gross classification of hepatocellular carcinoma (HCC) according to the Korean Liver Cancer Association (KLCA) guidelines. Methods: A retrospective analysis was performed on 242 cases of consecutively resected solitary primary HCC between 2003 and 2012 at Seoul National University Bundang Hospital. The gross classification (vaguely nodular [VN], expanding nodular [EN], multinodular confluent [MC], nodular with perinodular extension [NP], and infiltrative [INF]) was reviewed for all cases, and were correlated with various clinicopathological features and the expression status of “stemness”-related (cytokeratin 19 [CK19], epithelial cell adhesion molecule [EpCAM]), and epithelial-mesenchymal transition (EMT)–related (urokinase plasminogen activator receptor [uPAR] and Ezrin) markers. Results: Significant differences were seen in overall survival (p = .015) and disease-free survival (p = .034) according to the gross classification; INF type showed the worst prognosis while VN and EN types were more favorable. When the gross types were simplified into two groups, type 2 HCCs (MC/NP/INF) were more frequently larger and poorly differentiated, and showed more frequent microvascular and portal venous invasion, intratumoral fibrous stroma and higher pT stages compared to type 1 HCCs (EN/VN) (p < .05, all). CK19, EpCAM, uPAR, and ezrin expression was more frequently seen in type 2 HCCs (p < .05, all). Gross classification was an independent predictor of both overall and disease-free survival by multivariate analysis (overall survival: p = .030; hazard ratio, 4.118; 95% confidence interval, 1.142 to 14.844; disease-free survival: p = .016; hazard ratio, 1.617; 95% confidence interval, 1.092 to 2.394). Conclusions: The gross classification of HCC had significant prognostic value and type 2 HCCs were associated with clinicopathological features of aggressive behavior, increased expression of “stemness”- and EMT-related markers, and decreased survival.
참고문헌 (20)
- Liver Cancer Study Group of Japan, "General rules for the clinical and pathological study of primary liver cancer" (2003), Kanehara & Co.
- Kanai T, "Pathology of small hepatocellular carcinoma: a proposal for a new gross classification", Cancer, 60, pp.810~819 (1987)[DOI]
- Choi GH, "Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification", Am J Surg, 198, pp.693~701 (2009)[DOI]
- Fu X, "Gross classification of solitary small hepatocellular carcinoma on preoperative computed tomography: prognostic significance after radiofrequency ablation", Hepatol Res, 46, pp.298~305 (2016)[DOI]
- Gong SC, "The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma", J Gastroenterol Hepatol, 31, pp.206~212 (2016)[DOI]
- Hui AM, "Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy", J Hepatol, 33, pp.975~979 (2000)[DOI]
- Inayoshi J, "Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment", J Gastroenterol Hepatol, 18, pp.673~677 (2003)[DOI]
- Murakata A, "Gene expression signature of the gross morphology in hepatocellular carcinoma", Ann Surg, 253, pp.94~100 (2011)[DOI]
- Shimada M, "The role of macroscopic classification in nodular-type hepatocellular carcinoma", Am J Surg, 182, pp.177~182 (2001)[DOI]
- Trevisani F, "Gross pathologic types of hepatocellular carcinoma in Italian patients: relationship with demographic, environmental, and clinical factors", Cancer, 72, pp.1557~1563 (1993)[DOI]
- Tsujita E, "The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma", Hepatogastroenterology, 60, pp.1726~1730 (2013)
- "A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators", Hepatology, 28, pp.751~755 (1998)
- 장재영, "The General Rules for the Study of Primary Liver Cancer", Journal of Liver Cancer, 17(1), pp.19~44 (2017), 대한간암학회
- Kurogi M, "Clinicopathological study of scirrhous hepatocellular carcinoma", J Gastroenterol Hepatol, 21, pp.1470~1477 (2006)
- International Consensus Group for Hepatocellular Neoplasia, "Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia", Hepatology, 49, pp.658~664 (2009)[DOI]
- Kim H, "Human hepatocellular carcinomas with "stemness"-related marker expression: keratin 19 expression and a poor prognosis", Hepatology, 54, pp.1707~1717 (2011)[DOI]
- Kim H, "Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics", Dig Dis, 32, pp.778~785 (2014)[DOI]
- Lee JM, "The epithelial-mesenchymal transition: new insights in signaling, development, and disease", J Cell Biol, 172, pp.973~981 (2006)[DOI]
- Okamura D, "Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection", Mod Pathol, 21, pp.847~855 (2008)[DOI]
- Zhou L, "Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma", Pathol Int, 50, pp.392~397 (2000)[DOI]